Historically, depression researchers have examined continuity in terms of whether the symptoms and characteristics of mild, moderate, and severe depression differ in degree along a continuum (i.e., a quantitative difference) or in kind (i.e., qualitative difference). The authors propose a differentiated framework that distinguishes 4 direct tests of continuity (i.e., phenomenological, typological, etiological, and psychometric continuity). They use this framework to suggest that most evidence is consistent with the continuity hypothesis. Moreover, they maintain that the findings of future research can be incorporated into a 2-factor model of depression that allows for both continuities and discontinuities.
Much of the existing psychological literature on depression is based on research with college students. An important question is whether depression in college students represents an appropriate analogue of depression in clinical patients. The purpose of the present article is to review past evidence on this issue from a critical perspective. Past arguments are examined, and little support is found for the position that depression research with college students is not warranted. Moreover, the results of studies with student and clinical samples are compared, and the findings are generally similar across populations. Next, a number of methodological issues are identified that may actually favor the use of depressed college students, and some methodological recommendations for future research are outlined. Finally, an appeal is made for research that directly examines the analogue-clinical issue and the nature of college student depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.